Guest guest Posted November 16, 2001 Report Share Posted November 16, 2001 I wonder if the US will even take a look at this study. A vaccine that is not necessary would cost the pharmaceutical company's to much $$$. All of you who know parents that are still vaccinating should let them know about this. Acellular Pertussis Vaccinations in Infancy Provide Protection up to Age 6 ------------------------------------------------------------------------------ -- WESTPORT, CT (Reuters Health) Nov 07 - The protection against pertussis afforded by three doses of diphtheria-tetanus-acellular pertussis vaccine (DTaP) administered at 2, 4 and 6 months of age persists through 6 years of age, Italian investigators report. Dr. Stefania Salmaso, of the Instituto Superiore di Sanitá in Rome, and colleagues have prospectively followed children who received vaccinations between 1992 and 1993. They have previously reported protective efficacy of 84% in the first 2 years of life, which persisted through age 33 months. As reported in the November issue of Pediatrics, in this third stage of followup from ages 3 to 6, occurrence of pertussis was monitored until the end of 1998. Included were 4217 children who had received the Kline Beecham DTaP vaccine, 4215 who had received vaccine manufactured by Chiron-Biocine, and 1122 who had been given diphtheria-tetanus vaccines only. Parents were telephoned monthly and asked about episodes of coughing that lasted at least 7 days. Dr. Salmaso's team identified 122 episodes of laboratory-confirmed pertussis, as well as an additional 163 episodes in which titers of serum IgG against pertussis toxin or filamentous hemagglutinin were elevated. The efficacy of the two vaccines was 78% to 81%, based on case definition as laboratory-confirmed infection with at least 14 days of spasmodic cough or at least 21 days of any cough. The Italian researchers found that mean duration of cough among the cases was 47 to 48 days among those who received DTaP vaccines and 70 days for those who received DT vaccine. " These findings suggest that even 5 years after primary immunization, most of the 'vaccine failures' show a milder clinical presentation of pertussis, " they write. They suggest that, so long as immunity to diphtheria and tetanus is maintained, the fourth dose of DTaP can be postponed until preschool age if a child had received three doses in infancy. Pediatrics 2001;108:e81 [http://www.pediatrics.org/] ------------------------------------------------------------------------------ -- Copyright © 2001 Reuters Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.